Meyer-Rath G

The long wait for long-acting HIV prevention and treatment formulations
Venter W, Gandhi M, Sokhela S, Sikwese K, Bygrave H, Gama L, Mphothulo N, Jamieson L, Siedner M, Pozniak A, Rojo P, Baptiste S, Wambui J, Meyer-Rath G, Honermann B, Warren M, Bekker L, Sinxadi P, Collins S, Burry J, Möller K, Clayden P, Owen A, Hill A

The Lancet HIV

(2024)

https://doi.org/10.1016/S2352-3018(24)00173-5
The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa
Masuku S, Brennan A, Vetter B, Venter F, Mtshazo B, Sokhela S, Mashabane N, Kao K, Meyer-Rath G

BMC Public Health

(2024)

https://doi.org/10.1186/s12889-024-19253-8
What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations.
Meyer-Rath G, Jamieson L, Pillay Y

Journal of the International AIDS Society

(2023)

https://doi.org/10.1002/jia2.26106
The role of modelling in planning and budgeting for South Africa’s COVID-19 response
Silal SP, Pulliam JRC, Jamieson L, Nichols B, Moultrie H, Meyer-Rath G

PLOS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001063
Integration of point-of-care screening for type 2 diabetes mellitus and hypertension with COVID-19 rapid antigen screening in Johannesburg, South Africa
Brennan AT, Vetter B, Majam M, Msolomba VT, Venter F, Carmona S, Kao K, Gordon A, Meyer-Rath G

PLoS ONE

(2023)

https://doi.org/10.1371/journal.pone.0287794
The role of modelling and analytics in South African COVID-19 planning and budgeting
Meyer-Rath G, Hounsell RA, Pulliam JRC, Jamieson L, Nichols BE, Moultrie H, Silal SP

PLoS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001063
Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa
Jamieson L, van Schalkwyk C, Nichols BE, Meyer-Rath G, Silal SP, Pulliam JRC, Blumberg L, Cohen C, Moultrie H, Jassat W

PLoS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001073
The National COVID-19 Epi Model (NCEM): estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
Silal SP, Pulliam JRC, Meyer-Rath G, Jamieson L, Nichols BE, Norman J, Hounsell R, Mayet S, Kagoro F, Moultrie H

PLoS Global Public Health

(2023)

https://doi.org/10.1371/journal.pgph.0001070
Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa
Silal SP, Groome MJ, Govender N, Pulliam JRC, Ramadan PC, Jassat W, Leonard E, Moultrie H, Meyer-Rath G, Ramkrishna W, Langa T, Furumele T, Moonasar D, Cohen C, Walaza S

The South African Medical Journal

(2022)

https://doi.org/10.7196/SAMJ.2022.v112i5b.16061
Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa
Pearson CAB, Silal SP, Li MWZ, Dushoff J, Bolker BM, Abbott S, van Schalkwyk C, Davies NG, Barnard RC, Edmunds WJ, Bingham JL, Meyer-Rath G, Glass A, Wolter N, Govender N, Stevens W, Scott L, Mlisana K, Moultrie H, Pulliam JRC

medRxiv

(2021)

https://doi.org/10.1101/2021.12.19.21268038
Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 treatment in South Africa
Youngji J, Jamieson L, Edoka I, Long L, Silal SP, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE

Open Forum Infectious Diseases

(2021)

https://doi.org/10.1093/ofid/ofab040
The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing intensive care unit capacity
Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal SP, Pulliam JRC, Sanne I, Meyer-Rath G

Clinical Infectious Diseases

(2020)

https://doi.org/10.1093/cid/ciaa937